Morgan Stanley Maintains Equal-Weight on Docebo, Raises Price Target to $39
Morgan Stanley analyst Josh Jennings maintains Docebo (NASDAQ:DCBO) with a Equal-Weight and raises the price target from $36 to $39.
Canaccord Genuity Maintains Buy on Docebo, Raises Price Target to $50
Canaccord Genuity analyst Robert Young maintains Docebo (NASDAQ:DCBO) with a Buy and raises the price target from $40 to $50.
General Electric, Build-A-Bear Workshop, Asana And Other Big Stocks Moving Higher On Thursday
U.S. stocks traded higher, with the Dow Jones gaining around 50 points on Thursday. Here are some big stocks recording gains in today’s session.
Earnings Scheduled For March 9, 2023
Companies Reporting Before The Bell
• Aurora Mobile (NASDAQ:JG) is expected to report earnings for its fourth quarter.
Morgan Stanley Maintains Equal-Weight on Docebo, Lowers Price Target to $36
Morgan Stanley analyst Josh Baer maintains Docebo (NASDAQ:DCBO) with a Equal-Weight and lowers the price target from $40 to $36.
Earnings Scheduled For August 11, 2022
Companies Reporting Before The Bell
• Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million.
90 Biggest Movers From Yesterday
Gainers
Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) surged 70.5% to close at $0.1330 on Thursday after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered direct offering.
58 Stocks Moving In Thursday’s Mid-Day Session
Gainers
Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 102.6% to $0.1580 after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered direct offering.
Docebo Q1 EPS $(0.21) Down From $(0.17) YoY, Sales $32.10M Beat $29.80M Estimate
Docebo (NASDAQ:DCBO) reported quarterly losses of $(0.21) per share. This is a 23.53 percent decrease over losses of $(0.17) per share from the same period last year. The company reported quarterly sales of $32.10